Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LP-184 by Lantern Pharma for Melanoma: Likelihood of Approval
LP-184 is under clinical development by Lantern Pharma and currently in Phase I for Melanoma. According to GlobalData, Phase I...